Contribute Try STAT+ Today

The McKinsey & Co. consulting firm has reached a $573 million settlement with 47 states over its work advising Purdue Pharma and other drug makers to aggressively market opioid painkillers.

This is the first national settlement to emerge from the massive opioid litigation filed by state, county, and local governments against opioid manufacturers over the past several years. The deal is also the first to result in a substantial payment to the states to address the epidemic. The funds will be used for prevention, treatment, and recovery efforts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Comments are closed.